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1. BACKGROUND 
 
Certain categories of cosmetic ingredients are regulated under the EU Cosmetic Regulation 
1223/2009 to ensure consumer safety. These include the ingredients listed in the Annexes of 
the EU Cosmetic Regulation (colorants, preservatives, UV filters,), the list of 26 potential 
allergens (see SCCS/1559/11), and any nanomaterial in cosmetic ingredient. Detailed guidance 
on the testing of cosmetic ingredients and their safety assessment has been provided in the 
SCCS Notes of Guidance (9th revision, SCCS/1564/15).  
 
The Regulation also specifically covers the use of nanomaterials in cosmetic products. In this 
respect, the Regulation provides a definition of a nanomaterial under Article 2 (1) (k), and 
requires the European Commission to be notified six months prior to placing a cosmetic product 
containing nanomaterial(s) on the market. If there are concerns over the safety of a 
nanomaterial, the Commission will refer it to the Scientific Committee on Consumer Safety 
(SCCS) for a scientific Opinion. The Regulation requires the nanoscale ingredients used in 
cosmetic products to be labelled (name of the ingredient, followed by ‘nano’ in brackets). This 
provides a mechanism for premarket notification, risk assessment, authorisation, and labelling 
of cosmetic products that contain nanomaterials. The SCCS has already published a specific 
Guidance on the main elements to consider when submitting a safety dossier on nanomaterials 
in cosmetics (SCCS/1484/12) and a memorandum on the relevance, adequacy and quality of 
the data presented in such dossiers (SCCS/1524/13).  
 
For timely assessment of the dossiers submitted in support of safety of cosmetics ingredients, 
it is of utmost importance that they are as complete as possible and contain data that are 
adequate, relevant, and of suitable quality for use in risk assessment. In this context, this 
document provides checklists for the parameters that are essential for the SCCS evaluation of 
cosmetic ingredients, including nanomaterials in cosmetics. The main purpose of these 
checklists is to enable both the Applicant and the SCCS to quickly assess if the dossiers are 
complete and to prevent submissions that are incomplete or contain inadequate/irrelevant 
data. This should streamline the safety evaluation process and save time and resources for 
both the Applicants and the SCCS.   
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2. CHECKLISTS FOR COSMETIC INGREDIENTS (Not for nanomaterials) 
2.1 Completeness of the dossier 
 
Information required Answer 
Same number of annexes as  provided in 
the summary 
             
Same content of annexes as provided in 
the summary 
             
Consistency in numbering              
 
2.2 General information on the cosmetic ingredient 
 
Information required Answer 
Type of cosmetic ingredient 
(preservative, UV-filter, colourant, hair dye, other) 
             
Maximal concentration in finished cosmetic product  
leave-on 
rinse-off 
 
             
             
Exposure  
(oral, dermal, inhalation) 
             
Current use(s)              
 
 
The checklists provide a maximum of 4 possible options for the Applicant to fill in the columns. 
In some cases, only one or two options are available. The Applicant shall select only one option 
by double clicking on the most appropriate one to indicate the answer as follows: 
YES The required information or documentation is included.  
IN PART Only partial information or documentation is included. Justification for the 
missing elements must be provided in a separate document. 
NO The required information or documentation is not included in the dossier. 
Reasons for not providing the information must be included in a separate 
document. 
NOT RELEVANT The information or documentation is not relevant or requested for the 
application in question. Justification for their non-submission must be provided 
in a separate document. 
SCCS/1588/17 
 
Checklists for Applicants Submitting Dossiers on Cosmetic Ingredients 
_____________________________________________________________________________________________________________________ 
 7
 
 
Confidentiality of commercial name(s) to be considered?              
 
 
 
Table 2.1: Checklist for minimal physicochemical characterisation 
 
Information required Provided? 
Primary name and/or INCI name              
CAS / EC number              
Structural formula              
Empirical formula              
Physical form              
Molecular weight              
Purity and isomer composition*              
Impurities/accompanying contaminants              
Solubility              
Partition coefficient (Log Pow)              
Homogeneity               
Stability              
* for substances which are mixtures of isomers 
 
 
Table 2.2: Checklist for more specific physicochemical characterisation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Information required Provided? 
Organoleptic properties              
Flash point               
For liquids: 
 boiling point 
 relative density 
 pKa 
 viscosity 
 vapour pressure 
             
             
             
             
             
             
For solids: 
 general appearance 
 melting temperature 
 pKa 
             
             
             
             
For gases: 
 density 
 auto-ignition temperature 
             
             
             
UV light absorption spectrum**              
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** for UV light-absorbing substance 
 
Table 2.3: Checklist for hazard identification (toxicological data) 
 
Information required Reference Provided?
Likelihood and extent of internal 
exposure via skin, lung, or oral route 
considering the use type 
Section 3-4.1 of SCCS/1564/15 
             
Dermal absorption SCCS/1358/10              
Acute Toxicity Section 3-4.2 of SCCS/1564/15              
Irritation and Corrosivity Section 3-4.3 of SCCS/1564/15              
Skin Sensitisation Section 3-4.4 of SCCS/1564/15              
Mutagenicity/ Genotoxicity Section 3-4.7 of SCCS/1564/15              
Repeated dose toxicity Section 3-4.5 of SCCS/1564/15              
Phototoxicity - for products intended 
for use in sunlight-exposed skin 
Section 3-4.9 of SCCS/1564/15              
Reproductive Toxicity (a) Section 3-4.6 of SCCS/1564/15              
Developmental Toxicity Section 3-4.6 of SCCS/1564/15              
Carcinogenicity (b) Section 3-4.8 of SCCS/1564/15              
Human data (where available) Section 3-4.10 of SCCS/1564/15 
and SCCNFP/0633/02 
             
Other relevant information               
(a) Where points 1 and 2 indicate significant systemic uptake 
(b) Where points 1 and 2 indicate significant systemic uptake and/or bioaccumulation 
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Table 2.4: Checklist for information on exposure 
 
Information required (a) Provided? 
Category of cosmetic products in which the ingredient is intended for use              
Concentration of the ingredient in the finished cosmetic product              
Quantity of the product used at each application              
Frequency of use              
Total area of skin contact              
Duration of exposure              
Foreseeable uses which may increase exposure              
Consumer target groups (e.g., children, people with sensitive, damaged or 
compromised skin) where specifically required              
Quantity likely to enter the body (fraction absorbed) for each target group              
Application on skin areas exposed to sunlight              
Estimated dermal exposure based on the intended use of the product              
Estimated oral exposure based on the intended use of the product              
Estimated inhalation exposure based on the intended use of the product              
Exposure calculation for each target group              
Other relevant information              
(a) In the absence of information, default values for some of the parameters may be used (SCCS Notes of Guidance 
SCCS/1564/15) 
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3. CHECKLISTS FOR NANOMATERIALS IN COSMETICS 
 
The SCCS Guidance (SCCS/1484/12) has recommended that, as a minimum, the data provided 
on characterisation of nanomaterials intended for use in a cosmetic product should include a 
clear description of  
1. the pristine nanoparticles as produced (raw material),  
2. the nanoparticles present in the cosmetic product (after formulation), and  
3. the nanoparticles present during toxicological investigations covering realistic exposure 
scenarios for the exposure assessments  
If characterisation of a nanomaterial at any of these stages is not feasible, for example, due to 
the lack of methods, or due to degradation of the nanomaterial, it should be justified and 
documented. 
Other important issues as highlighted in the SCCS Memorandum (SCCS/1524/13) are the 
following: 
- The data provided in a safety dossier should contain detailed characterisation in relation 
to the unequivocal/unambiguous identity and composition of the nanomaterial(s) that are 
intended for use in the final product. 
- The toxicity data provided in a safety dossier should include a detailed description of the 
materials and methods used and appropriate statistical indicators of the quality and 
reliability of the test results. 
- Safety of a nanomaterial cannot be assumed on the argument that the bulk form of the 
materials is safe (and vice versa), without specific evidence to support it. 
- If data from other materials are included (e.g. a bulk material as a comparator), it should 
be clearly defined and segregated from the data on nanomaterials, and not presented 
mixed-up with data on nanomaterial(s) under evaluation. 
- Each submission should be supported by comprehensive data from the Applicants’ studies 
as well as any relevant information available from the open literature. To facilitate the 
evaluation, the contents should be divided into general aspects and specific aspects. The 
submission should be in the form of a searchable text or pdf file with page numbering and 
appropriate indexing of the contents and supporting studies and publications in clear 
sections and separated appendices/annexes. Scanned files that are not searchable and 
embedded files within documents will not be accepted. 
- Unless there is a close similarity between different nanomaterials, it is advisable to 
include a complete set of supporting data on each nanomaterial rather than presenting 
several different nanomaterials in a single, patchy and data-poor submission. If the same 
data included in the dossier is considered relevant for evaluation of more than one 
nanomaterial, the basis for ‘similarity’ between the nanomaterials must also be provided 
to allow data read-across.  
- Inclusion of irrelevant data – for example from unrelated materials, or materials with 
incomplete or unknown characterisation – must be avoided. 
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A schematic outline of nanomaterial risk assessment is given in the Figure attached to this 
document. 
The following checklists provide a maximum of 4 possible options for an Applicant to fill in the 
columns as explained below. In some cases, only one or two options are available. The 
Applicant shall select only one option by double clicking on the most appropriate one to indicate 
the answer as follows: 
YES The required information or documentation is included.  
IN PART Only partial information or documentation is included. Justification for the 
missing elements must be provided in a separate document.  
NO The required information or documentation is not included in the dossier. 
Reasons for not providing the information must be included in a separate 
document.  
NOT RELEVANT The information or documentation is not relevant or requested for the 
application in question. Justification for their non-submission must be provided 
in a separate document. 
 
 
Confidentiality of commercial name(s) to be considered?              
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Table 3.1: Checklist for material characterisation 
Information required(a) Provided for raw 
material as 
manufactured? 
Provided for 
material in a final 
formulation? 
Provided for material 
used for toxicological 
investigations and 
exposure assessment? 
Chemical identity                                        
Chemical composition                                        
Particle size(b)                                        
Morphology                                        
Surface Characteristics                                        
Solubility                                        
Surface area                                        
Catalytic Activity                                        
Concentration(c)                                        
Dustiness(c)                                        
Density and pour density(d)                                        
Redox potential                                        
pH(e)                                        
Viscosity(f)                                        
Stability                                        
UV absorption                                        
Other                                        
(a) For details on these parameters see Table 1 of SCCS/1484/12; (b) For any spray product, size distribution of the 
droplets after spraying as well as of the dried residual particles should be provided; (c) For dry powder products only; (d) 
For granular materials only; (e) For aqueous solutions; (f) For liquid dispersions  
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Table 3.2: Checklist for Hazard Identification (Toxicological data) 
Information required Reference Provided? 
Likelihood and extent of internal 
exposure via skin, lung or oral route 
considering the use type 
Section 3-4.1 of SCCS/1564/15 
             
Dermal absorption – for dermally 
applied products 
SCCS/1358/10              
Biokinetic behaviour, aggregation/ 
agglomeration considered during tests? 
Section 3-4.1 of SCCS/1564/15              
Acute Toxicity Section 3-4.2 of SCCS/1564/15              
Irritation and Corrosivity Section 3-4.3 of SCCS/1564/15              
Skin Sensitisation Section 3-4.4 of SCCS/1564/15              
Mutagenicity/ Genotoxicity(a) Section 3-4.7 of SCCS/1564/15              
Repeated dose toxicity Section 3-4.5 of SCCS/1564/15              
Phototoxicity - for products intended 
for use in sunlight-exposed skin 
Section 3-4.9 of SCCS/1564/15              
Reproductive Toxicity (b) Section 3-4.6 of SCCS/1564/15              
Carcinogenicity (c) Section 3-4.8 of SCCS/1564/15              
Human data (where available) Section 3-4.10 of SCCS/1564/15 
and SCCNFP/0633/02              
Other relevant information   
(a) The Ames test is not considered appropriate for nanomaterial mutagenicity assessment. The following scheme 
based on in vitro assays is proposed (SCCS/1564/15). 
1. An in vitro mammalian cell gene mutation test (e.g. hprt, tk or xprt tests).  
2. Mammalian cell chromosome aberration/clastogenicity – determined either by in vitro chromosome aberration 
test or micronucleus test. The micronucleus test can be performed by the mononucleate or cytokinesis 
blocked protocols. In the cytokinesis blocked micronucleus assay, co-exposure to both cytochalasin B and the 
test nanomaterial for the duration of the experiment is not considered acceptable. 
Additionally, other alternative tests, such as the Comet assay, may be included as further weight of evidence. 
New in vitro approaches such as cell transformation assays or toxicogenomic approaches may also be useful 
for identification of genotoxic as well as non-genotoxic carcinogen nanomaterials. 
3. In vitro genotoxicity studies should be accompanied by an assessment of cellular and nuclear uptake to 
demonstrate target exposure.   
(b) Where point 1 and 2 of the above table indicate significant systemic uptake 
(c) Where point 1 and 2 of the above table indicate significant systemic uptake and/or bioaccumulation 
 
 
 
 
 
 
 
SCCS/1588/17 
 
Checklists for Applicants Submitting Dossiers on Cosmetic Ingredients 
_____________________________________________________________________________________________________________________ 
 14
 
Table 3.3: Checklist for Information on Exposure (for details see page 19 of SCCS 
1484/12) 
Information required (a) Provided? 
Category of cosmetic products in which the ingredient is intended for use              
Concentration of the ingredient in the finished cosmetic product              
Quantity of the product used at each application              
Frequency of use              
Total area of skin contact              
Duration of exposure              
Foreseeable uses which may increase exposure              
Consumer target groups (e.g., children, people with sensitive, damaged or 
compromised skin) where specifically required              
Quantity likely to enter the body (fraction absorbed) for each target group              
Application on skin areas exposed to sunlight              
Estimated dermal exposure based on the intended use of the product              
Estimated oral exposure based on the intended use of the product              
Estimated inhalation exposure based on the intended use of the product              
Exposure calculation for each target group              
Other relevant information              
(a) In the absence of information, default values for some of the parameters may be used (SCCS Notes of Guidance 
SCCS/1564/15) 
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Figure 3.1: Schematic outline for the safety assessment of nanomaterials in 
cosmetics: 
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Cosmetic Ingredient
Physicochemical characterisation 
considering nano related aspects 
(Table 1*)  
Is the ingredient or its breakdown 
product a nanomaterial according 
to (EC) 1223/2009, Article 2(1)(k)?
Exposure Assessment considering 
possible routes  (Table 2)
Hazard identification and dose-
response effect characterisation of 
nanomaterials
Physicochemical characterisation -
Is the material still in the 
nanoscale?
YES
NO
* i.e. in raw material, final formulation and as used for toxicological investigations and exposure assessment; 
Local  effects
Systemic exposure 
possible? 
(Table 3)
YES
YES
NO
 
